Mechanism of Action of Methotrexate: Experimental Evidence that Methotrexate Blocks the Binding of Interleukin 1 β to the Interleukin 1 Receptor on Target Cells

Clinical Chemistry and Laboratory Medicine

Volumn 31, Issue 10, 1993, Pages 667-674

  Brody, Marlene ^a   Böhm, Ingrid ^a   Bauer, R ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INDOMETACIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; METHOTREXATE; METHYLPREDNISOLONE;

ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DRUG THERAPY; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATORY DISEASE; LYMPHOCYTE; MONOCYTE; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR BLOCKING; TARGET CELL;

FLOW CYTOMETRY; GRANULOCYTES; HUMAN; IN VITRO; INDOMETHACIN; INTERLEUKIN-1; LYMPHOCYTES; METHOTREXATE; METHYLPREDNISOLONE; MONOCYTES; RECEPTORS, INTERLEUKIN-1;

EID: 84961490074     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.1993.31.10.667     Document Type: Article

References (42)

1. Beuscher, H. U., Rausch, U. P. & Rollinghoff, M. (1992) Die Rolle von Interleukin 1 bei Infektionen und Sepsis. Immun. Infect. 20, 128–133.
2. Bigler, C. F., Norris, D. A., Weston, W. L. & Arend, W. P. (1992) Interleukin 1 receptor antagonist production by human keratinocytes. J. Invest. Dermatol. 98, 38–44.
3. Schwartz, T., Urbanska, A., Gschnait, F. & Luger, T. A. (1987) UV-irradiated epidermal cells produce a specific inhibitor of interleukin activity. J. Immunol. 138, 1456–1463.
4. Wahl, S. M., Hunt, D. A. & Wong, H. L. (1988) Transforming growth factor ß is a potent immunosuppressive agent that inhibits interleukin 1-dependent lymphocytes proliferation. J. Immunol. 140, 3026–3032.
5. Jolivet, J., Cowan, K. H., Curt, G. A., Clendininn, N. J. & Chabner, B. A. (1983) The pharmacology and clinical use of methotrexate. N. Engl. J. Med. 309, 1094–1104.
6. Wang, Y. M. & Loo, T. L. (1981) Mechanism of action of methotrexate. Cancer Bull. 33, 49–54.
7. Segal, R., Mozes, E., Yaron, M. & Tartakovsky, B. (1989) The effects of methotrexate on the production and activity of interleukin 1. Arthritis Rheum. 32, 370–377.
8. Young, I. T. (1977) Proof without prejudice: Use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources. J. Histochem. Cytochem. 25, 935–941.
9. Dinarello, C. A. & Wolff, S. M. (1993) The role of interleukin 1 in disease. N. Engl. J. Med. 328, 106–113.
10. Dinarello, C. A. (1984) Interleukin 1. Rev. Infect. Dis. 6, 51–95.
11. Ristow, H. J. (1990) Interleukin 1 does not stimulate DNA synthesis of cultured human keratinocytes growth arrested in growth-factor-depleted medium. J. Invest. Dermatol. 95, 688–692.
12. Dustin, M. L., Rothlein, R., Bhan, A. K., Dinarello, C. A. & Springer, T. A. (1986) Induction by interleukin 1 and y IFN: Tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). J. Immunol. 137, 245–254.
13. Luger, T. A. & Schwarz, T. (1990) Evidence for an epidermal cytokine network. J. Invest. Dermatol. 95, 1005–1033.
14. Dinarello, C. A., Ikejima, T., Warner, S. J. C., Orencole, S. F., Lonnemann, G., Cannon, J. G. & Libby, P. (1987) Interleukin 1 induces interleukin 1. I. Induction of circulation interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. J. Immunol. 139, 1902–1910.
15. Warner, S. J. C., Auger, J. R. & Libby, P. (1987) Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells. J. Exp. Med. 165,1316–1331.
16. Warner, S. J. C., Auger, J. R. & Libby, P. (1987) Interleukin 1 induces interleukin 1. II. Interleukin 1 induces production of interleukin 1 by adult human vascular endothelial cells in vitro. J. Immunol. 139, 1911–1917.
17. Schroder, J. M., Sticherling, M., Henneicke, H. H., Preissner, W. C. & Christophers, E. (1990) Interleukin 1 a or TNF alpha stimulates release of three IL-8 related neutrophil chemotactic proteins in human dermal fibroblasts. J. Immunol. 144, 2223–2232.
18. Schroder, J. M. & Christophers, E. (1989) Secretion of novel and homologous neutrophil activating peptides by LPS-stimulated human endothelial cells. J. Immunol. 142, 244–251.
19. Aribia, N. B., Leroy, E. & Lautz, O. (1987) Recombinant IL-2 induced proliferation of human circulating NK cells and T lymphocytes: Synergistic effects of interleukin 1 and IL-2. J. Immunol. 139, 443–451.
20. Eastgate, J. A., Symons, J. A., Wodd, N. C., Grinlinton, F. M., de Giovine, F. S. & Duff, G. W. (1988) Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet 2, 706–209.
21. Volc-Platzer, B. (1992) Graft versus host disease. Hautarzt 43, 669–677.
22. Maury, C. P. J. & Teppo, A. M. (1988) Serum immunoreactive interleukin 1 in renal transplant recipients. Association of raised levels with graft rejection episodes. Transplantation 45, 143–147.
23. Estrov, Z., Kurzrock, A., Estey, E., Wetzlar, M., Ferrajoli, A., Harris, D., Blake, M., Gutterman, J. U. & Talpaz, M. (1992) Inhibition of acute myelogenous leukemia blast proliferation by interleukin 1 receptor antagonist and soluble interleukin 1 receptors. Blood 79, 1938–1945.
24. Cooper, K. D., Hammerberg, C., Baadsgaard, O., Elder, J. T., Chan, L. S., Taylor, R. S., Voorhees, J. J. & Fisher, G. (1988) Interleukin 1 in human skin: dysregulation in pso-riasis. J. Invest. Dermatol. 95, 24S—26S.
25. Gomi, T., Shiohara, T., Munakata, T., Imanishi, K. & Nagashima, M. (1991) Interleukin lα, tumor necrosis factor a and interferon y in psoriasis. Arch. Dermatol. 127, 827–830.
26. Fujiwara, H., Kleinherz, M. E., Wallis, R. S. & Ellner, J. J. (1986) Increased interleukin 1 production and monocyte suppressor cell activity associated with human tuberculosis. Am. Rev. Respir. Dis. 133, 73–77.
27. Watson, S., Bullock, W., Nelson, K., Shauf, V., Gelber, R. & Jacobson, R. (1984) Interleukin 1 production by peripheral blood mononuclear cells from leprosy patients. Infect. Immun. 45, 787–789.
28. Tron, V. A., Rosenthal, D. & Sauder, D. N. (1988) Epidermal interleukin 1 is increased in cutaneous T-cell lymphoma. J. Invest. Dermatol. 90, 378–381.
29. Tanaka, Y., Saito, K., Suzuki, H., Eto, S. & Yamashita, U. (1989) Inhibitory effect of anti class II antibody on the spontaneous activation of B cells in patients with systemic lupus erythematosus. Analysis with interleukin 1 production and interleukin 1 receptor expression. J. Immunol. 143, 1584–1590.
30. Kremer, J. M. % Lee, J. K. (1988) A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Arthritis Rheum. 31, 577–584.
31. Black, R. L., O’Brien, W. M. & Van Scott, E. J. (1964) Methotrexate therapy in psoriatic arthritis. Double blind study on 21 patients. J. Am. Med. Assoc. 189, 743–777.
32. Nyfors, A. (1986) Methotrexate therapy in psoriasis and psoriatic arthritis. A review. Rheumatology 9, 60–87.
33. Kozarek, R. A., Patterson, D. J., Gelfand, M. D., Botoman, V. A., Ball, T. J. & Wilske, K. R. (1989) Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann. Intern. Med. 110, 353–356.
34. Lally, E. V. (1989) The use of methotrexate in the treatment of Reiter's syndrome, polymyositis, dermatomyositis and other connective tissue diseases. In: Methotrexate therapy in rheumatic disease (Wilke, E. S., ed.) New York Dekker, pp. 295–312.
35. Bergasa, N. V., Hoofnagle, J. H., Axiotis, C. A., Rabin, L., Park, Y. & Jones, E. A. (1991) Oral methotrexate for primary biliary cirrhosis, preliminary report. Gastroenterology 100, A720.
36. Storb, R., Deeg, J. H. & Whitehead, J. (1986) Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantion for leukemia. N. Engl. J. Med. 314, 729–735.
37. Zackheim, H. S. & Epstein, E. H. (1989) Low-dose methotrexate for the Sezary syndrome. J. Am. Acad. Dermatol. 21,757-762.
38. Mullarkey, M. F., Lammert, J. K. & Blumenstein, B. A. (1990) Long-term methotrexate treatment in corticosteroid-dependent asthma. Ann. Intern. Med. 112, 577–581.
39. Cream, J. J. & Pole, D. S. (1980) The effect of methotrexate and hydroxyurea on neutrophil chemotaxis. Br. J. Dermatol. 102, 557–560.
40. Lammers, A. M., van de Kerkhof, P. C. M. & Mier, P. D. (1987) Reduction of leukotriene B4-induced intraepidermal accumulation of polymorphonuclear leukocytes by methotrexate in psoriasis. Br. J. Dermatol. 116, 667–671.
41. Ternowitz, Th., Bjerring, P., Anderson, P. H., Schorder, J. M. & Kragballe, K. (1987) Methotrexate inhibits the human C5a-induced skin response in patients with psoriasis. J. Invest. Dermatol. 89, 192–196.
42. Johnson, W. J., Di Martino, M. J., Meunier, P. C., Muir-head, K. A. & Hanna, N. (1988) Methotrexate inhibits macrophage activation as well as vascular and cellular inflammatory events in rat adjuvant induced arthritis. J. Rheumatol. 15, 745–749.